University Of Antwerp

The medical center is at the forefront of research in psychiatry and mental health, with a particular focus on innovative treatment strategies for Major Depressive Disorder (MDD). The center's research aims to enhance therapeutic outcomes for patients who have not achieved remission through conventional antidepressant treatments.

• Immune-targeted augmentation therapies
• Inflammation-based stratification
• Advanced treatment protocols for MDD

By exploring the efficacy of immune-targeted therapies such as minocycline and celecoxib, the center contributes significantly to the development of personalized medicine approaches in mental health care. This research is particularly focused on patients who have not responded to standard antidepressant regimens, offering new hope for improved management of MDD.